Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01257568 · ClinicalTrials.gov registry record · NA
Rejuvenate Modular Outcomes Study
A NA study, sponsored by Stryker Orthopaedics.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT01257568 is a NA study that has completed, run by Stryker Orthopaedics. The registered enrollment target is 42 participants.
The verdict
NCT01257568, a NA study, has completed, sponsored by Stryker Orthopaedics.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
This study will be an evaluation of the Rejuvenate® Modular Hip System for primary total hip replacement (THR) with a cementless application in a consecutive series of patients who meet the eligibility criteria. Subjects will be evaluated for freedom of hip revision at 5 years and clinical outcomes for up to 10 years after surgery.
Interventions
- DEVICE Rejuvenate Modular Hip
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2010-11 |
| Est. Completion | 2022-01-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01257568
The ClinicalTrials.gov registry entry for NCT01257568 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stryker Orthopaedics, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Rejuvenate Modular Hip is the first listed.
NCT01257568 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01257568 about?
NCT01257568 is a clinical study titled "Rejuvenate Modular Outcomes Study". This study will be an evaluation of the Rejuvenate® Modular Hip System for primary total hip replacement (THR) with a cementless application in a consecutive series of patients who meet the eligibility criteria. Subjects will be evaluated for freedom of hip revision at 5 years and clinical outcomes ...
What is the current status of trial NCT01257568?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2010-11. Estimated completion is 2022-01-20.
What interventions are being tested in trial NCT01257568?
The interventions under investigation include: Rejuvenate Modular Hip (DEVICE).
Who is sponsoring clinical trial NCT01257568?
This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.